J.P. Morgan Maintains Rating, PT Following Presentation By ARIA

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

J.P. Morgan is maintaining its Overweight rating, along with its $10 price target on Ariad Pharmaceuticals (NASDAQ: ARIA) following the company's recent presentation at the ASCO Conference.Says J.P. Morgan, in its report, “We reiterate our OW rating on ARIA following presentations yesterday afternoon (after market close) of the Ph3 SUCCEED results for rida in soft tissue and bone sarcoma at the annual American Society of Clinical Oncology (ASCO) conf. in Chicago. Overall, we believe the data are compelling enough to warrant approval. While we continue to view ponatinib (CML) as the key value driver (pivotal data expected 4Q), we suspect increasing confidence in rida could add further support to the stock.”ARIA closed at $7.91 yesterday.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!